143 related articles for article (PubMed ID: 12957095)
1. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries.
Metzger ML; Howard SC; Fu LC; Peña A; Stefan R; Hancock ML; Zhang Z; Pui CH; Wilimas J; Ribeiro RC
Lancet; 2003 Aug; 362(9385):706-8. PubMed ID: 12957095
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area.
Howard SC; Pedrosa M; Lins M; Pedrosa A; Pui CH; Ribeiro RC; Pedrosa F
JAMA; 2004 May; 291(20):2471-5. PubMed ID: 15161898
[TBL] [Abstract][Full Text] [Related]
3. Childhood acute lymphoblastic leukemia managed in tertiary care center in a developing country.
Dabbous IA; Dbouk H; Sibai AM; Bahlawan L
Med Pediatr Oncol; 2003 Jul; 41(1):83-4. PubMed ID: 12764756
[No Abstract] [Full Text] [Related]
4. Comparing childhood leukaemia treatment before and after the introduction of a parental education programme in Indonesia.
Mostert S; Sitaresmi MN; Gundy CM; Janes V; Sutaryo ; Veerman AJ
Arch Dis Child; 2010 Jan; 95(1):20-5. PubMed ID: 19679573
[TBL] [Abstract][Full Text] [Related]
5. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
Navarrete M; Rossi E; Brivio E; Carrillo JM; Bonilla M; Vasquez R; Peña A; Fu L; Martinez R; Espinoza CM; Lacayo LF; Rodriguez H; Batista R; Barr R; Howard SC; Ribeiro RC; Masera G; Biondi A; Conter V; Valsecchi MG
Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
[TBL] [Abstract][Full Text] [Related]
6. Survival outcome of childhood acute lymphoblastic leukemia in India: a resource-limited perspective of more than 40 years.
Kulkarni KP; Arora RS; Marwaha RK
J Pediatr Hematol Oncol; 2011 Aug; 33(6):475-9. PubMed ID: 21792045
[TBL] [Abstract][Full Text] [Related]
7. The problem of treatment abandonment in children from developing countries with cancer.
Arora RS; Eden T; Pizer B
Pediatr Blood Cancer; 2007 Dec; 49(7):941-6. PubMed ID: 17252565
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
[TBL] [Abstract][Full Text] [Related]
9. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America.
Gupta S; Antillon FA; Bonilla M; Fu L; Howard SC; Ribeiro RC; Sung L
Cancer; 2011 Oct; 117(20):4788-95. PubMed ID: 21446043
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of childhood acute lymphoblastic leukemia treated in China.
Tang Y; Xu X; Song H; Yang S; Shi S; Wei J
Pediatr Blood Cancer; 2008 Sep; 51(3):380-6. PubMed ID: 18506765
[TBL] [Abstract][Full Text] [Related]
11. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia.
Mostert S; Sitaresmi MN; Gundy CM; Sutaryo ; Veerman AJ
Pediatrics; 2006 Dec; 118(6):e1600-6. PubMed ID: 17074838
[TBL] [Abstract][Full Text] [Related]
12. Simple deliverable therapy needed for childhood leukaemia.
Lilleyman J
Lancet; 2003 Aug; 362(9385):676-7. PubMed ID: 12957086
[No Abstract] [Full Text] [Related]
13. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.
Pui CH; Gaynon PS; Boyett JM; Chessells JM; Baruchel A; Kamps W; Silverman LB; Biondi A; Harms DO; Vilmer E; Schrappe M; Camitta B
Lancet; 2002 Jun; 359(9321):1909-15. PubMed ID: 12057554
[TBL] [Abstract][Full Text] [Related]
14. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
[TBL] [Abstract][Full Text] [Related]
15. Pediatric convulsive status epilepticus in Honduras, Central America.
Molinero MR; Holden KR; Rodriguez LC; Collins JS; Samra JA; Shinnar S
Epilepsia; 2009 Oct; 50(10):2314-9. PubMed ID: 19694798
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
Lund B; Åsberg A; Heyman M; Kanerva J; Harila-Saari A; Hasle H; Söderhäll S; Jónsson ÓG; Lydersen S; Schmiegelow K;
Pediatr Blood Cancer; 2011 Apr; 56(4):551-9. PubMed ID: 21298739
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, predictors, causes of treatment refusal and abandonment in children with acute lymphoblastic leukaemia over 18 years in North India. Treatment phase affecting factors: A step towards better focussed counselling.
Alam A; Kumar A
Cancer Epidemiol; 2018 Dec; 57():53-59. PubMed ID: 30316108
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
19. Treating leukemia in a resource poor setting.
Menon J; Mathews L; Purushothaman KK
Indian Pediatr; 2008 May; 45(5):410-2. PubMed ID: 18515933
[TBL] [Abstract][Full Text] [Related]
20. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.
Escherich G; Horstmann MA; Zimmermann M; Janka-Schaub GE;
Leukemia; 2010 Feb; 24(2):298-308. PubMed ID: 20016530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
